INNOVACAP Share Price

INNOVACAP Share Price

NSE: INNOVACAP
|
Pharmaceuticals
|
S Cap
₹ 1,147.20
-₹20.20 (-1.73%)
1D
Last updated 11 Sep, 2026, 15:56 IST

INNOVACAP Share Price Today

As of 13 Sep 2026, INNOVACAP share price is ₹1,147.20. The stock opened at ₹1,150.10, compared to its previous close of ₹1,167.40. During today's trading session, INNOVACAP share price moved in the range of ₹1,133.10 to ₹1,168.10, with an average price of ₹1,150.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹622.00 and a high of ₹1,200.00. On the performance front, INNOVACAP share price has increased by 64.90% over the last six months and is up 33.38% on a year-on-year basis.

₹1,133.10
1.73% down today
₹1,168.10
1D LOW
1D HIGH

INNOVACAP Returns Calculator

Circuit
L
H
₹917.80
₹1,376.60
52-week
L
H
₹622.00
₹1,200.00

About INNOVACAP

INNOVACAP Share Price
ISIN
INE0DUT01020
Sector Market Cap
₹ 6,556.26 Cr

Innova Captab Limited is an integrated pharmaceutical company. The Company is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It has a presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes Contract Development and Manufacturing (CDMO) Services and Products, Domestic Branded Generics, and International Branded Generics. Its CDMO business provides research, product development and manufacturing services. Its Branded Generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. It has developed a diversified branded generics product portfolio including tablets, capsules, dry syrups, and others.

INNOVACAP Financial Highlights

  • Revenue: INNOVACAP reported revenue of ₹1,637.44 crore in FY26 vs ₹1,255.73 crore in FY25. It showed an increase of 30.40% on a yearly basis.
  • Operating Profit: INNOVACAP reported an operating profit of ₹188.26 crore in FY26 vs ₹171.02 crore in FY25. It showed an increase of 10.08% on a year-on-year basis.
  • Net Profit: INNOVACAP reported a net profit of ₹140.92 crore in FY26 vs ₹128.26 crore in FY25. It showed an increase of 9.87% on a yearly basis.

INNOVACAP Quarterly Result Highlights

  • INNOVACAP reported revenue of ₹472.86 crore in Jun 2026, compared with ₹449.36 crore in Mar 2026, representing an increase of 5.23% on a quarter-on-quarter (QoQ) basis.
  • INNOVACAP reported an operating profit of ₹58.99 crore in Jun 2026, compared with ₹50.68 crore in Mar 2026, representing an increase of 16.40% on a quarter-on-quarter (QoQ) basis.
  • INNOVACAP reported a profit of ₹44.13 crore in Jun 2026, compared with ₹38.08 crore in Mar 2026, reflecting an increase of 15.89% on a QoQ basis.
  • The earnings per share (EPS) of INNOVACAP stood at ₹24.63 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
50.90%
FII
0.34%
Other DII
10.74%
Retail and other
28.84%
Mutual funds
9.18%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.08%
Dec 20250.11%
Mar 20260.23%
Jun 20260.34%
Mkt Cap Cr
6,556.26
P/E
42.56
P/B
6.01
ROE
12.92%
D/E
0.36
ROCE
14.30%
Div. Yield
0.17%
EPS(TTM)
14.63
Turnover
0.91
EV/EBITDA
25.68
Net Margin
6.44%
Op. Margin
12.67%
ROA
8.38%
Quick Ratio
1.32
Curr. Ratio
2.43
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Innova Captab outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Innova Captab appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Innova Captab revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,41,958.0036.485.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,47,576.0084.6414.7715.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,233.0087.7722.5025.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,11,671.0024.324.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,273.0032.863.2011.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,06,460.0097.6420.0916.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories96,906.4030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma96,401.7025.982.549.25%0.1911.76%394.820.24%0.3841.58
Lupin95,842.9017.274.2723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,050.4045.495.7711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

INNOVACAP Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,630.02₹1,243.68₹1,081.31₹926.38
Other Income₹7.42₹12.05₹12.49₹9.20
Total Revenue₹1,637.44₹1,255.72₹1,093.79₹935.58
Total Expenses₹1,449.17₹1,084.71₹964.27₹843.78
Profit Before Tax₹188.26₹171.02₹129.53₹91.80
Tax₹47.35₹42.76₹35.18₹23.84
Profit After Tax₹140.92₹128.26₹94.35₹67.95
EPS - Basic₹24.63₹22.41₹18.66₹14.16
EPS - Diluted₹24.63₹22.41₹18.66₹14.16

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹188.26₹171.02₹129.53₹91.80
Income before WC changes₹245.90₹198.40₹166.69₹117.71
Change in Assets-₹224.54-₹140.14₹11.43-₹46.98
Change in Liabilities₹121.41₹29.30-₹4.11₹15.92
Change in WC-₹103.13-₹110.84₹7.31-₹31.06
Cash flow from Operations₹116.52₹63.84₹146.34₹67.12
Cash flow from Investing-₹107.12-₹151.59-₹498.97-₹90.84
Cash flow from Financing-₹21.72₹91.53₹360.83₹27.09
Total Cash Flow-₹12.32₹3.79₹8.20₹3.37
Cash (Start of the year)₹15.52₹11.73₹3.53₹0.15
Cash (End of the year)₹3.20₹15.52₹11.73₹3.53

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹914.42₹884.71₹741.13₹261.95
Current Assets₹922.96₹695.69₹579.75₹442.47
Total Assets₹1,837.38₹1,580.41₹1,320.88₹704.41
Current Liabilities₹494.58₹353.00₹265.48₹277.55
Net Current Asset₹428.38₹342.69₹314.27₹164.92
Non-Current Liabilities₹252.01₹267.99₹224.51₹150.36
Equity Capital₹1,090.79₹959.42₹830.89₹276.51
Total Equity & Liabilities₹1,837.38₹1,580.41₹1,320.88₹704.41

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹1,298.81₹958.06₹864.93₹858.67
Other Income₹13.24₹16.78₹10.72₹8.73
Total Revenue₹1,312.06₹974.84₹875.65₹867.41
Total Expenses₹1,200.24₹854.95₹781.95₹789.10
Profit Before Tax₹111.82₹119.89₹93.70₹78.31
Tax₹28.13₹30.42₹25.54₹20.76
Profit After Tax₹83.69₹89.47₹68.16₹57.55
EPS - Basic₹14.63₹15.63₹13.48₹11.99
EPS - Diluted₹14.63₹15.63₹13.48₹11.99

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹111.82₹119.89₹93.70₹78.31
Income before WC changes₹152.93₹129.27₹116.01₹101.89
Change in Assets-₹217.99-₹115.03₹11.39-₹51.98
Change in Liabilities₹119.74₹24.95₹8.26₹8.28
Change in WC-₹98.25-₹90.08₹19.65-₹43.70
Cash flow from Operations₹34.11₹19.80₹111.67₹39.28
Cash flow from Investing-₹14.06-₹99.75-₹471.55-₹87.53
Cash flow from Financing-₹33.99₹83.86₹368.13₹51.29
Total Cash Flow-₹13.94₹3.92₹8.25₹3.03
Cash (Start of the year)₹15.31₹11.39₹3.14₹0.10
Cash (End of the year)₹1.37₹15.31₹11.39₹3.14

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹797.26₹836.04₹717.63₹299.96
Current Assets₹749.83₹529.11₹437.44₹378.38
Total Assets₹1,547.09₹1,365.14₹1,155.07₹678.34
Current Liabilities₹414.25₹290.16₹213.40₹259.32
Net Current Asset₹335.58₹238.94₹224.04₹119.06
Non-Current Liabilities₹246.18₹262.02₹217.95₹150.70
Equity Capital₹886.65₹812.97₹723.72₹268.32
Total Equity & Liabilities₹1,547.09₹1,365.14₹1,155.07₹678.34
* All values are in INR Crore
Qty
Bid
127
1147.2
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 127
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
62.97
Neutral
ATR (14)
45.19
Neutral
STOCH(9,6)
64.3
Neutral
STOCH RSI (14)
47.5
Neutral
ADX(9)
46.96
Bearish
UO(9)
45.94
Neutral
ROC(12)
11.24
Bullish
WillR(14)
-27.94
Neutral
Period
Simple value
Exponential vaue
5D
1167.9
1157.83
10D
1139.51
1138.84
20D
1095.02
1102.75
50D
1025.06
1036.01
100D
950.19
961.69
Volume trend — traded volume by day
11 Sep0L
10 Sep0L
9 Sep0L
8 Sep0L
7 Sep1L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
INNOVACAP Share Price
INNOVACAP
Pharmaceuticals
Add Stock
Add Another

INNOVACAP Share Price FAQs

INNOVACAP share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837